Trials / Completed
CompletedNCT01506466
Weight Variation During Chemotherapy in Breast Cancer Patients
Weight Variation and Mechanisms Involved, During Chemotherapy in Breast Cancer Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Centre Jean Perrin · Academic / Other
- Sex
- Female
- Age
- 70 Years
- Healthy volunteers
- Not accepted
Summary
Weight variation has been reported as a side effect of chemotherapy treatment in early breast cancer patients. To date, there is growing evidence for an increased risk of relapse and death in these patients who gain or lose weight. However, causes of weight variation during chemotherapy and mechanisms involved in the poor prognosis have been little studied. Thus, the investigators are conducting a prospective study to characterize weight variation in terms of body composition and to identify the mechanisms involved.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | blood test/ additional measurement | blood test (hormonal, inflammatory, lipid and growth factors); body composition measurements; energy balance evaluation |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2013-03-01
- Completion
- 2014-01-01
- First posted
- 2012-01-10
- Last updated
- 2015-07-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01506466. Inclusion in this directory is not an endorsement.